Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,772 across all filing types
Latest filing 2024-12-12 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec SE announces first projects for LAB eN2 drug discovery accelerator with Novo Nordisk
Regulatory Filings Classification · 1% confidence The document is a news release dated December 11, 2024, announcing a corporate development: Evotec SE's collaboration with Novo Nordisk on the LAB eN² drug discovery accelerator, including the selection of initial projects and the expansion of participating academic institutions. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It is a general corporate announcement disseminated via EQS News. Since it is a specific corporate update that doesn't fit the highly specific categories like DIRS, DIV, or CAP, and it is not a short announcement pointing to a separate report (RPA), the most appropriate general category for miscellaneous corporate news disseminated through official channels is Regulatory Filings (RNS), which often serves as a catch-all for non-standard press releases that are still required to be disclosed.
2024-12-12 English
Evotec SE announces first projects for LAB eN2 drug discovery accelerator with Novo Nordisk
M&A Activity Classification · 1% confidence The document is a news release dated December 11, 2024, announcing a corporate development: Evotec SE's collaboration with Novo Nordisk on the LAB eN² drug discovery accelerator, including the selection of initial projects and the expansion of participating academic institutions. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It is a general corporate announcement disseminated via EQS News. Since it is a specific corporate update that doesn't fit the highly specific categories like DIRS, DIV, or CAP, and it is not a short announcement pointing to a separate report (RPA), the most appropriate general category for miscellaneous corporate news disseminated through official channels is Regulatory Filings (RNS), which often serves as a catch-all for non-standard press releases that are still required to be disclosed.
2024-12-11 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Evotec SE: Correction of a release from 27/11/2024 according to Article 40, Section 1 of the WpHG' and explicitly contains a section titled 'Notification of Major Holdings'. It details the acquisition/disposal of shares with voting rights by Connor, Clark & Lunn Financial Group Ltd., crossing a threshold of 3.06% voting rights on November 15, 2024. This content directly relates to reporting changes in significant share ownership, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the detailed disclosure of a major holding change, making MRQ the most specific fit over DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2024-12-03 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Evotec SE: Correction of a release from 27/11/2024 according to Article 40, Section 1 of the WpHG' and explicitly contains a section titled 'Notification of Major Holdings'. It details the acquisition/disposal of shares with voting rights by Connor, Clark & Lunn Financial Group Ltd., crossing a threshold of 3.06% voting rights on November 15, 2024. This content directly relates to reporting changes in significant share ownership, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the detailed disclosure of a major holding change, making MRQ the most specific fit over DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2024-12-02 English
Declaration of Compliance of the German Corporate Governance Code for the Year 2024 (December 2024)
Governance Information Classification · 1% confidence The document text explicitly discusses compliance with the 'German Corporate Governance Code' (DCGK), detailing specific exceptions related to board member mandates, remuneration structures (long-term variable remuneration, short-term variable remuneration/Bonus), and the role of the Management Board and Supervisory Board. This content directly relates to the company's internal rules, board structure, and governance practices as mandated by German corporate law. This aligns perfectly with the definition of Governance Information (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or a general Earnings Release (ER).
2024-12-01 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement titled 'Total Voting Rights Announcement' released on 29.11.2024. It explicitly references compliance with Article 41 of the WpHG (German Securities Trading Act) and details a 'Conditional capital increase' effective 30.11.2024, resulting in a new total number of voting rights (177,553,456). This type of filing, which reports changes in the total number of shares/voting rights due to corporate actions (like capital increases), fits best under the 'Share Issue/Capital Change' category (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a director's dealing (DIRS).
2024-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.